Global Molecular Transport Medium Market Set for 4.5% CAGR Growth, Hitting $1,214 Million by 2034

Increasing Need for Dependable Sample Preservation in Diagnostic Procedures Fueling Molecular Transport Medium Market: Fact.MR Report

The net revenue from sales of molecular transport mediums in 2024 is expected to be around US$ 785.3 million. The molecular transport industry is projected to grow at a CAGR of 4.5% through 2034. The value of the market is anticipated to reach up to US$ 1,214 million by 2034.

The increasing need for dependable sample preservation in diagnostic procedures is driving the demand for molecular transport mediums. The market is evolving as key players are investing heavily in the development and adoption of universal transport mediums to ensure integrity and stability for a range of molecular investigations. These aspects are expected to boost market growth.

The molecular transport medium market was valued at US$ 234.6 million in 2019. A higher demand for viral transport mediums following the COVID-19 pandemic skyrocketed the overall market demand during the years 2020 and 2021. Swab transfer mediums emerged as a reliable transport option for samples gathered at far sites due to the necessity of remote patient monitoring.

“Leading market players have ensured a safe and traceable transportation of biological samples by continuing innovation in labeling and packaging. To scale up their business, new market participants have to follow compliance standards due to strict regulatory requirements for sample transfer in the molecular diagnostics sector,” says a Fact.MR analyst.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9527

Key Takeaways from the Global Molecular Transport Medium Market Study Report

• The North American market is poised to develop at a CAGR of 4.8% and reach a valuation of US$ 516 million by 2034.
• The United States is leading the production and utilization of molecular transport mediums, which is poised to advance at 4.9% CAGR through 2034.
• The East Asia market is estimated to be valued at US$ 125 million in 2024.
• The market in China is expected to reach up to US$ 103 million by 2034, rising from US$ 59 million in 2024.
• Based on the product type, the inactivated transport medium segment is observed to account for more than 60% of the global market demand.

Leading Players Driving Innovation in the Molecular Transport Medium Market:

Key industry participants like Thermo Fisher Scientific Inc.; Becton, Dickinson, and Company; Cardinal Health; Quidel Corporation; Medical Wire & Equipment; COPAN Diagnostics Inc.; Titan Biotech Ltd.; Alpha Teknova, Inc. [former named Teknova]; Bio-Genex Laboratories Inc.; EKF Diagnostics; Trinity Biotech; Alpha-Tec Systems, Inc.; Charm Sciences, Inc.; Azer Scientific; bioBoaVista; AccuGene; KSL Diagnostics; Puritan Medical Products; Amazing Biotech (Shanghai) Co., Ltd. etc. are driving the molecular transport medium industry.

Competitive Landscape

The overall market is highly consolidated as very few market players have been able to scale up their business due to stringent regulatory standards in the healthcare sector. Partnerships with molecular transport medium suppliers across different end-use sectors are expected to slow down the market fragmentation to some extent.

Recent Developments by the Molecular Transport Medium Industry Participants

1. In October 2020, EKF Diagnostics Center introduced the PrimeStore molecular transport medium (MTM) kit for the proper and secure collection, handling, and transportation of pathogenic samples. Soon, EKF had to increase its manufacturing capacity in the United Kingdom and other European countries to accommodate the increasing demand for this sample-collecting tool.
2. In March 2022, Thermo Fisher Scientific Incorporation unveiled its new product line of InhibiSure, which is a formulation of a viral inactivation medium. A wide range of viruses can be collected and transported safely with the help of this non-hazardous medium, which also helps to stabilize viral RNA during its transportation.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9527

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the global molecular transport medium market, presenting historical demand data and forecast statistics for the period (2024 to 2034).

The molecular transport medium industry survey report covers key segments based on product type, application, sample, end-user verticals, and region. Product types include active and inactivated transport mediums. Applications span viruses like COVID-19, MERS, influenza, HIV, rhinovirus, adenovirus, and RSV, along with bacterial infections such as Staphylococcus pneumonia, Haemophilus influenza, anthrax, and atypical bacteria like Mycoplasma and Q-fever. Samples include nasal washes, sputum, saliva, stool, urine, blood, and tissues. End users are diagnostic and microbiology laboratories, hospitals, and clinics. Geographically, the market spans North America, Europe, Latin America, Asia, and MEA.

Check out More Related Studies Published by Fact.MR Research:

Molecular diagnostics reagent market size is anticipated to accelerate at a 6.6% CAGR from 2024 to 2034. The global demand for molecular diagnostic reagents is expected to attain US$ 20,009.6 million by 2034, from an estimated US$ 10,584.3 million market size in 2024.

Swab sticks market was valued at USD 2,055 million in 2024 and is projected to reach USD 4,091 million by 2035.

Viral antigens market is estimated at US$ 175.9 billion in 2022 and is forecasted to expand at a high-value CAGR of 8.2% to reach a market size of US$ 388.1 billion by the end of 2032.

Polyisobutylene (PIB) market is estimated to evolve at a CAGR of 5.6% and hit a valuation of US$ 4 billion by 2033, up from US$ 2.3 billion in 2023.

Dehydration membrane market was valued at US$ 1,464.9 million in 2023 and has been forecasted to expand at a noteworthy CAGR of 4.3% to end up at US$ 2,310.4 Million by 2034.